Aggregated price index with volume information
Summary:
- Hospital/Nursing Management stocks down 0.7% on average while median return down 0.6% in a day
- Hospital/Nursing Management stocks up 2.0% on average while median return up 0.8% in a week
- Hospital/Nursing Management stocks up 11.6% on average while median return up 10.3% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are $JYNT 44.5%, $THC 41.1%, $CYH 29.9%, $SEM 28.5%, $UHS 15.7%
- 1M losers are : Losers for past month are $TDOC -3.4%, $PINC -5.4%, $VMD -8.8%
- 1W winners are : Winners for past week are $CYH 11.8%, $ALC 8.3%, $TDOC 6.5%, $NHC 5.7%, $JYNT 4.7%
- 1W losers are : Losers for past week are $HCA -1.2%, $EHC -1.2%, $BKD -2.1%, $CIVI -2.2%, $SGRY -2.9%
Correlation Analysis
Index correlation analysis
Correlation for the past month is 15.3%, for the past 3 months is 16.5%
In the past month for a 5 days rolling window, the highest corrrelation is 43.0%, the lowest correlation is -4.9%, the latest correlation is 32.0%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 82.1% between HCA and UHS
The lowest correlation is -33.6% between PINC and SGRY
Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.
Per Maravai LifeSciences (MRVI) management, this development by TriLink is set to advance nucleic acid-based therapies.
Investors are optimistic about Haemonetics (HAE) led by its strategic focus on establishing leading positions in high-growth markets to generate solid financial returns.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
On May 15, 2024, Helen Boudreau, a director at Premier Inc (NASDAQ:PINC), executed a sale of 6,629 shares of the company.
Michael Burry is in the news for two reasons. One, he has revealed his Q1’2024 portfolio that shows Burry is once again swimming against the tide (more on that later). Second, amid the return of Roaring Kitty on Twitter, meme stock boys on Reddit and Twitter are recalling how Burry was the first notable investor […]
Encompass Health (EHC) remains well-poised for growth on the back of robust demand for effective inpatient rehabilitation services, joint ventures and solid cash reserves.
Prestige Consumer's (PBH) Q4 business suffers from supply chain pressure that impacts its ability to fulfill retailer orders.
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
DENVER, May 16, 2024--Civitas Resources, Inc. Announces Pricing of Secondary Public Offering